StonvexLoading…
StonvexStonvexStonvexCore line items from AXIL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-05-31 | Annual 2024 2024-05-31 | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 |
|---|---|---|---|---|
Revenue | $26.26M | $27.50M | $23.52M | $2.34M |
Operating Income | $1.16M | $1.50M | $1.98M | $-211.40K |
Net Income | $854.99K | $2.00M | $1.82M | $-182.90K |
EPS (Diluted) | $0.10 | $0.21 | $0.10 | $0.00 |
Total Assets | $12.87M | $10.97M | $10.17M | $893.91K |
Total Liabilities | $3.21M | $3.28M | $3.50M | $709.20K |
Cash & Equivalents | $4.77M | $3.25M | $4.83M | $373.73K |
Free Cash Flow OCF − CapEx | $1.72M | $-135.77K | $2.85M | Not available |
Shares Outstanding | 6.66M | 5.91M | 5.86M | 41.95M |